Literature DB >> 9024788

Import of plasmid DNA into the nucleus is sequence specific.

D A Dean1.   

Abstract

Nuclear import of plasmid DNA in nondividing cells is a process essential to the success of numerous viral life cycles, gene therapy protocols, and gene expression experiments. Here, intact protein-free SV40 DNA was cytoplasmically injected into cells and its subcellular localization was followed by in situ hybridization. SV40 DNA localized to the nucleus consistent with a mechanism of transport through the nuclear pore complex (NPC): import was inhibited by the addition of the NPC-inhibitory agents wheat germ agglutinin and an anti-nucleoporin antibody as well as by energy depletion. DNA transport appeared to be a multistep process with the DNA accumulating at the nuclear periphery before its import. Most importantly, nuclear import was sequence specific: a region of SV40 DNA containing the origin of replication and the early and late promoters supported import, whereas bacterial sequences alone and other SV40-derived sequences did not. The majority of the imported DNA colocalized with the SC-35 splicing complex antigen, suggesting that the intranuclear DNA localizes to areas of transcription or message processing. This link to transcription was strengthened by the finding that inhibition of transcription blocked DNA import but not protein nuclear import. Taken together, these results support a model in which plasmid DNA nuclear import occurs by a mechanism similar to that used by nuclear localization signal-containing proteins but is also dependent on transcription.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024788     DOI: 10.1006/excr.1996.3427

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  79 in total

1.  Sequence requirements for plasmid nuclear import.

Authors:  D A Dean; B S Dean; S Muller; L C Smith
Journal:  Exp Cell Res       Date:  1999-12-15       Impact factor: 3.905

2.  Nuclear import of plasmid DNA in digitonin-permeabilized cells requires both cytoplasmic factors and specific DNA sequences.

Authors:  G L Wilson; B S Dean; G Wang; D A Dean
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

3.  Cell-specific nuclear import of plasmid DNA.

Authors:  J Vacik; B S Dean; W E Zimmer; D A Dean
Journal:  Gene Ther       Date:  1999-06       Impact factor: 5.250

4.  Dendrimer-assisted patch-clamp sizing of nuclear pores.

Authors:  J O Bustamante; E R Michelette; J P Geibel; J A Hanover; T J McDonnell; D A Dean
Journal:  Pflugers Arch       Date:  2000-04       Impact factor: 3.657

Review 5.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

Review 6.  Nonviral gene transfer strategies for the vasculature.

Authors:  Jennifer L Young; David A Dean
Journal:  Microcirculation       Date:  2002-01       Impact factor: 2.628

7.  Quantitative analysis of correlation between number of nuclear plasmids and gene expression activity after transfection with cationic liposomes.

Authors:  Rieko Tachibana; Hideyoshi Harashima; Naoko Ide; Sachiko Ukitsu; Yasuko Ohta; Norio Suzuki; Hiroshi Kikuchi; Yasuo Shinohara; Hiroshi Kiwada
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

8.  Functional nuclear topography of transcriptionally inducible extra-chromosomal transgene clusters.

Authors:  Manja Meggendorfer; Claudia Weierich; Horst Wolff; Ruth Brack-Werner; Thomas Cremer
Journal:  Chromosome Res       Date:  2010-06-08       Impact factor: 5.239

9.  The effects of cyclic stretch on gene transfer in alveolar epithelial cells.

Authors:  Winna Taylor; Kerimi E Gokay; Chris Capaccio; Erica Davis; Matthew Glucksberg; David A Dean
Journal:  Mol Ther       Date:  2003-04       Impact factor: 11.454

10.  Hydroporation as the mechanism of hydrodynamic delivery.

Authors:  G Zhang; X Gao; Y K Song; R Vollmer; D B Stolz; J Z Gasiorowski; D A Dean; D Liu
Journal:  Gene Ther       Date:  2004-04       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.